Breaking News
Get 45% Off 0
👀 Ones to Watch: These bargain stocks won't stay cheap long
See Undervalued Stocks
Close

Calamos® Growth & Income Portfolio (0P00003CCB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
24.070 +0.010    +0.04%
14/02 - Delayed Data. Currency in USD
  • Morningstar Rating:
  • Total Assets: 33.33M
Type:  Fund
Market:  United States
Issuer:  Calamos
Asset Class:  Equity
Calamos Growth & Income Portfolio 24.070 +0.010 +0.04%

0P00003CCB Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Calamos Growth & Income Portfolio (0P00003CCB) fund. Our Calamos Growth & Income Portfolio portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 3.400 3.400 0.000
Stocks 75.840 75.840 0.000
Bonds 1.710 1.710 0.000
Convertible 15.570 15.570 0.000
Preferred 3.470 3.470 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 23.783 17.719
Price to Book 5.172 2.808
Price to Sales 3.744 1.969
Price to Cash Flow 17.189 11.394
Dividend Yield 1.145 2.039
5 Years Earnings Growth 11.774 11.041

Sector Allocation

Name  Net % Category Average
Technology 31.530 21.591
Financial Services 14.450 15.690
Communication Services 11.450 7.420
Consumer Cyclical 11.210 10.194
Healthcare 9.980 11.611
Consumer Defensive 6.490 6.694
Industrials 5.550 11.317
Energy 3.950 5.302
Basic Materials 2.990 3.695
Utilities 1.630 3.230
Real Estate 0.770 4.405

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Australasia
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 149

Number of short holdings: 1

Name ISIN Weight % Last Change %
  NVIDIA US67066G1040 5.99 138.85 +2.63%
  Apple US0378331005 5.77 244.60 +1.27%
  Microsoft US5949181045 5.23 408.43 -0.51%
  Alphabet A US02079K3059 4.33 185.23 -0.49%
  Amazon.com US0231351067 4.14 228.68 -0.73%
  Meta Platforms US30303M1027 2.03 736.67 +1.11%
  Broadcom US11135F1012 1.53 233.04 -1.17%
  Tesla US88160R1014 1.52 355.84 -0.03%
  JPMorgan US46625H1005 1.44 276.59 +0.10%
Boeing Co 6% PRF CONVERT 15/10/2027 USD 50 - Dep Rep 1/20th Sr A US0970232049 1.39 - -

Top Equity Funds by Calamos

  Name Rating Total Assets YTD% 3Y% 10Y%
  Calamos Growth & Income A 1.45B 2.77 8.59 11.02
  Calamos Growth & Income I 1.4B 2.80 8.87 11.29
  Calamos Growth A 1.26B 2.73 11.45 12.57
  Calamos Phineus Long/Short I 924.45M 3.95 4.08 -
  Calamos Growth I 394.41M 2.75 11.73 12.85
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00003CCB Comments

Write your thoughts about Calamos® Growth & Income Portfolio
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email